Abstract
Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have